Skip to Main Content
Olufunke Martin, M.D.

Olufunke Martin, M.D.

Titles and Appointments

Assistant Professor

Endowed Title
Dedman Family Scholar in Clinical Care
Schools
Medical School
Departments
Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Olufunke Y. Martin, M.D., is an Assistant Professor in the Department of Pediatrics, Division of Hematology and Oncology at UT Southwestern Medical Center.  She joined the UT Southwestern faculty in 2023.

     

    Dr. Martin earned her Bachelor of Science in Human Biology from Brown University.  She received her medical degree from Michigan State University College of Human Medicine and completed her pediatric residency training at Riley Hospital for Children in Indianapolis, Indiana.  Dr. Martin completed her pediatric hematology/oncology fellowship at Children’s National Hospital in Washington, D.C., where she was a T32 scholar and recipient of the American Society of Hematology Minority Hematology Fellow Award. She is currently pursuing a Master of Clinical Research through the National Institute of Health-Duke University Clinical Research Training Program. 

     

    Dr. Martin’s clinical interest is pediatric hematology, emphasizing improving patient-centered outcomes for individuals with sickle cell disease (SCD) and multi-modal approaches to vaso-occlusive pain management.  Her research focuses on the dynamics of red blood cell physiology and vaso-occlusive pain, utilizing red blood cell health biomarkers to investigate the clinical heterogeneity seen in SCD.

  • Education
    Medical School
    Michigan State University College of Human Medicine (2017)
    Residency
    Indiana University School of Medicine/Riley Hospital for Children (2020), Pediatrics
    Fellowship
    Children's National Medical Center (2023), Pediatric Hematology/oncology
  • Research Interest
    • Biomarkers
    • Hemoglobinopathies
    • Red blood cell disorders
    • Rheology
    • Sickle cell disease
  • Publications
    Intranasal fentanyl and impact of an emergency department pain protocol for sickle cell disease on hospitalization rates
    Martin OY, Thompson SM, Hays M, Jacob SA Blood Advances 2026 Feb 10 802-812
    Acute pain in pediatric patients with SCD without chronic pain is associated with elevated VCAM-1 and P-selectin adhesion
    Martin OY, Borhan R, Zaidi AU, Gao X, Ribbiso K, Darbari DS, Hines PC, Campbell AD Blood Vessels, Thrombosis and Hemostasis 2026 Feb 3
    Optimizing the right time to start sickle cell therapies
    Martin OY, Jacob SA Hematology. American Society of Hematology. Education Program 2025 Dec 2025 577-584
    Altered Mental Status in a 19-year-old Male with Hemophilia B
    Plaut IS, Martin OY, Kahn I, Mahmood LA Pediatrics in review 2024 Jun 45 346-349
    Disparity in HLA Typing Rates Among Hospitalized Pediatric Patients with Sickle Cell Disease
    Ayuk-Arrey AT, Martin OY, Darbari I, Abraham A, Nickel RS Transplantation and Cellular Therapy 2024 Jan 30 107-113
    Pancytopenia, Hepatomegaly, and Neurologic Abnormalities in Two Pediatric Patients
    Martin OY, Hamby DK, Graham BH, Jacob SA Pediatrics in review 2023 Oct 44 S29-S34
    The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron
    Martin OY, Margulies S, Speller-Brown B, Majumdar S, Darbari DS, Campbell AD British Journal of Haematology 2023 Aug 202 479-484
    Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital
    Martin OY, Darbari DS, Margulies S, Nickel RS, Leonard A, Speller-Brown B, Martin B, Barber JR, Webb J, Majumdar S, Sharron MP, Campbell AD Frontiers in Medicine 2023 10
    Emergency department provider survey regarding acute sickle cell pain management
    Martin OY, Thompson SM, Carroll AE, Jacob SA Journal of Pediatric Hematology/Oncology 2020 Aug 42 375-380
    Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era
    Martin OO, Moquist KL, Hennessy JM, Nelson SC Pediatric Blood and Cancer 2018 Jan 65
  • Honors & Awards
    • American Society of Hematology Minority Hematology Fellow Award Program
      American Society of Hematology (2022)
    • CATCH Implementation Grant
      American Academy of Pediatrics (2022)
    • T32 Scholar
      Childrens National Hospital Research Institute (2022)
    • American Society of Hematology Minority Resident Hematology Award Program
      American Society of Hematology (2019)
    • Frontiers in Science Program Scholar
      Association of Medical School Pediatric Department Chairs (2018)
    • Certificate in Leadership in Medicine for the Underserved
      Michigan State University College of Human Medicine (2017)
    • Morris Green Physician Scientist Development Award
      Riley Hospital for Children/Indiana University School of Medicine (2017-2020)
    • Lipscomb-Dean Family Scholarship for Leadership and Service to Community
      Michigan State University College of Human Medicine (2015)
    • MSU CHM Fellowship for Research Enhancement
      Michigan State University College of Human Medicine (2015-2016)
  • Professional Associations/Affiliations
    • American Academy of Pediatrics (2016-2023)
    • American Board of Pediatrics (2020)
    • Children's Oncology Group (2020-2023)
    • The American Society of Hematology (2019)